Pangen Biotech (XKRX:222110) Total Liabilities : ₩7,725 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Total Liabilities?

Pangen Biotech's Total Liabilities for the quarter that ended in Mar. 2024 was ₩7,725 Mil.

Pangen Biotech's quarterly Total Liabilities increased from Sep. 2023 (₩7,845.69 Mil) to Dec. 2023 (₩8,175.18 Mil) but then declined from Dec. 2023 (₩8,175.18 Mil) to Mar. 2024 (₩7,725.07 Mil).

Pangen Biotech's annual Total Liabilities declined from Dec. 2021 (₩22,179.05 Mil) to Dec. 2022 (₩3,454.20 Mil) but then increased from Dec. 2022 (₩3,454.20 Mil) to Dec. 2023 (₩8,175.18 Mil).

Pangen Biotech Total Liabilities Historical Data

The historical data trend for Pangen Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Total Liabilities Chart

Pangen Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

20,656.55

22,097.72

22,179.05

3,454.20

8,175.18

Pangen Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															4,059.62	7,097.23	7,845.69	8,175.18	7,725.07

Pangen Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pangen Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5710.648	+	(2.236	+	29.999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2432.295)
	=	8,175

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	20741.156	-	12565.978
	=	8,175

Pangen Biotech's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5206.008	+	(2.236	+	29.999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2486.823)
	=	7,725

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	24355.272	-	16630.206
	=	7,725

Pangen Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pangen Biotech (XKRX:222110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675

Website

http://www.pangen.com

Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech (XKRX:222110) Headlines

No Headlines